Faeth Therapeutics, Inc. FTH
Set alert
19.80 USD +0.57 +2.96%
As of Nov 3, 1:20 PM ET
18.82 Day range 20.42
7.89 52-week range 40.05
- YTD
- +85.57%
- 1 year
- +129.97%
- Open
- 18.85
- Prev close
- 19.23
- Mkt cap
- 514.48M
- Vol
- 105.38K
- Avg vol
- 373.52K
- EPS
- -60.86
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 18.82
- High
- 20.42
- Forward P/E
- -7.88
- Beta
- -0.28
- Short ratio
- 3.64
- Inst. own
- 78.84%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 13, 2026
- 50-d avg
- 30.99
- 200-d avg
- 22.28
- 1y target
- 54.64
Held by funds
15 US ETFs and mutual funds hold FTH · largest positions
Ownership
Held by insiders 1.62%
Held by institutions 78.84%
Float held by institutions 80.13%
Institutions 57
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Montanova Capital LLC | 7.82% | 2,020,103 | 78.97M | Jun 29, 2026 |
| Avoro Capital Advisors LLC | 5.59% | 1,444,039 | 56.45M | Jun 29, 2026 |
| Baker Bros. Advisors, LP | 4.98% | 1,286,411 | 50.29M | Jun 29, 2026 |
| Balyasny Asset Management LP | 4.03% | 1,042,198 | 40.74M | Jun 29, 2026 |
| Cormorant Asset Management, LP | 3.98% | 1,028,242 | 40.19M | Jun 29, 2026 |
| RA Capital Management, L.P. | 2.79% | 722,020 | 28.22M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 0.19% | 48,771 | 1.91M | Apr 29, 2026 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 0.06% | 15,907 | 621.80K | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.04% | 10,115 | 395.39K | Jun 29, 2026 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 0.02% | 4,560 | 178.25K | Jul 30, 2026 |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 0.01% | 1,360 | 53.16K | Apr 29, 2026 |
| iShares Trust-iShares Micro-Cap ETF | 0.01% | 3,192 | 124.78K | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CAMBRIAN BIOPHARMA INC | Beneficial Owner of more than 10% of a Class of Security | Sale | May 31, 2026 | 130,142 |
| HAHN STEPHEN M | Director | Conversion of Exercise of derivative security | Jun 14, 2026 | 44,763 |
| MILLENNIUM MANAGEMENT, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | Apr 6, 2026 | 0 |
| PARIKH ANAND KIRAN J.D. | Chief Executive Officer | Conversion of Exercise of derivative security | Jun 21, 2026 | 817,699 |
| PEYER JAMES | Beneficial Owner of more than 10% of a Class of Security | Sale | May 31, 2026 | 130,142 |
| STEPHENSON BRIAN C | Chief Financial Officer | Purchase | Jun 30, 2026 | 0 |